Related Experiment Video
Updated: May 28, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Marc De Hert1, Johan Detraux, Ruud van Winkel
1University Psychiatric Center, Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium. marc.de.hert@ uc-kortenberg.be
Abstract:
Antipsychotic medications can induce cardiovascular and metabolic abnormalities (such as obesity, hyperglycemia, dyslipidemia and the metabolic syndrome) that are associated with an increased risk of type 2 diabetes mellitus and cardiovascular disease. Controversy remains about the contribution of individual antipsychotic drugs to this increased risk and whether they cause sudden cardiac death through prolongation of the corrected QT interval. Although some drug receptor-binding affinities correlate with specific cardiovascular and metabolic abnormalities, the exact pharmacological mechanisms underlying these associations remain unclear. Antipsychotic agents with prominent metabolic adverse effects might cause abnormalities in glucose and lipid metabolism via both obesity-related and obesity-unrelated molecular mechanisms. Despite existing guidelines and recommendations, many antipsychotic-drug-treated patients are not assessed for even the most easily measurable metabolic and cardiac risk factors, such as obesity and blood pressure. Subsequently, concerns have been raised over the use of these medications, especially pronounced in vulnerable pediatric patients, among whom their use has increased markedly in the past decade and seems to have especially orexigenic effects. This Review outlines the metabolic and cardiovascular risks of various antipsychotic medications in adults and children, defines the disparities in health care and finally makes recommendations for screening and monitoring of patients taking these agents.
Insights
Antipsychotic medications increase cardiovascular and metabolic risks, including type 2 diabetes. This review details these risks in adults and children, highlighting monitoring needs.
Area of Science:
- Pharmacology
- Cardiology
- Endocrinology
Background:
- Antipsychotic medications are linked to cardiovascular and metabolic issues like obesity, hyperglycemia, and dyslipidemia.
- These adverse effects increase the risk of type 2 diabetes mellitus and cardiovascular disease.
- Controversy exists regarding specific drug contributions and mechanisms, including QT interval prolongation.
Purpose of the Study:
- To review the metabolic and cardiovascular risks associated with antipsychotic medications in adults and children.
- To define healthcare disparities in monitoring these risks.
- To provide recommendations for screening and monitoring patients on antipsychotic agents.
Main Methods:
- Literature review of antipsychotic medications' cardiovascular and metabolic risks.
- Analysis of pharmacological mechanisms and receptor-binding affinities.
- Examination of healthcare disparities and monitoring practices.
Main Results:
- Antipsychotic agents can cause glucose and lipid metabolism abnormalities through obesity-related and unrelated mechanisms.
- Despite guidelines, many patients on antipsychotics are not screened for key metabolic and cardiac risk factors.
- Increased use in pediatric populations raises concerns due to orexigenic effects.
Conclusions:
- Antipsychotic medications pose significant metabolic and cardiovascular risks requiring careful management.
- There are disparities in healthcare for monitoring these risks, particularly in vulnerable pediatric patients.
- Enhanced screening and monitoring protocols are essential for patients taking antipsychotic medications.
Related Concept Videos
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis and Antipsychotic Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
